Previous 10 | Next 10 |
Gainers: IceCure Medical (NASDAQ:ICCM) +15%, Kiromic BioPharma KRBP +12%, Eargo (NASDAQ:EAR) +12%, Context Therapeutics (NASDAQ:CNTX) +11%, Xeris Biopharma XERS +11%. Losers: ERYTECH Pharma ERYP -39%, Eyenovia EYEN -37%, Es...
Remark Holdings (NASDAQ:MARK) +266%. Sonim Technologies (NASDAQ:SONM) +96%. Creatd (NASDAQ:CRTD) +69% announces second NFT drop, includes photographs of former President Donald Trump PAE Incorporated (NASDAQ:PAE) +67% Amentum to buy PAE in an all-cash deal valued at ~$1.9 ...
Collaboration and option to license the XeriJect™ technology Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today ann...
Qualcomm and SSW Partners outbid Magna to buy Veoneer. Veoneer to pay a termination fee of $110 million to Magna. Meredith Corporation acquired by IAC/InterActiveCorp and Gray Television. For further details see: Merger Arbitrage Mondays - Qualcomm And SSW Partners Win T...
Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc are now subsidiaries of Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company leveraging its novel formulation technology platforms to develop and...
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the "Court") has approved the previously announced proposed a...
Xeris Pharmaceuticals, Inc. is purchasing Strongbridge Biopharma in a stock swap and contingent value rights transaction. Assuming approval of Strongbridge’s Recorlev, the combination will have three products on the market in 2022 while enjoying ~$50 million of merger synergies...
The Five9 - Zoom deal takes a turn for the worse. The spread on the Five9 deal drops further into negative territory. Tencent's acquisition of Sogou finally goes through almost a year after announcement. For further details see: Merger Arbitrage Mondays: Five9 Investors ...
Kansas City Southern leaves Canadian National Railway at the altar. Goldman Sachs Group uses its stock to acquire GreenSky for $2.24 billion by giving GreenSky shareholders 0.03 shares of Goldman Sachs. Veoneer receives an updated non-binding proposal from Qualcomm. For...
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals, wil...
News, Short Squeeze, Breakout and More Instantly...
Xeris Pharmaceuticals Inc. Company Name:
XERS Stock Symbol:
NASDAQ Market:
Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a range of therapies, today announced that the C...
John Shannon, President and Chief Operating Officer, to succeed Paul Edick as new CEO and Board Director Transition timing aligns with the solid financial position of the Company, including consistently strong growth from its commercial franchise, healthy cash position, and the track reco...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on July 1, 2024, the Compensation Committee of Xeris’ Boar...